12340 El Camino Real
San Diego, CA 92130
United States
858 450 4222
https://www.dermtech.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 206
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. William W. Zondler | Chief Information Officer | N/A | N/A | N/A |
Mr. Steve E. Kunszabo | Senior Director of Investor Relations | N/A | N/A | N/A |
Ms. Jennifer Eilemberg | Chief Compliance Officer | N/A | N/A | N/A |
Dr. Burkhard Jansen M.D. | Chief Medical Affairs Officer | 419.8k | N/A | 1966 |
Dr. Loren Clarke M.D. | Chief Medical Officer | N/A | N/A | N/A |
Dr. Steven Stone Ph.D. | Senior Vice President of Research & Development | N/A | N/A | N/A |
Mr. Mark Aguillard | Chief Commercial Officer | N/A | N/A | 1973 |
DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the psoriasis, atopic dermatitis, and aging of the skin to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California.
DermTech, Inc.’s ISS governance QualityScore as of 1 May 2024 is 7. The pillar scores are Audit: 7; Board: 6; Shareholder rights: 8; Compensation: 7.